Why is SPARC falling/rising?

As of 22-Sep, Sun Pharma Advanced Research Company Ltd (SPARC) is experiencing a decline in its stock price, currently at 141.10, which reflects a decrease of 2.2 or 1.54%. The stock has underperformed its sector today by 0.46% and has been on a consecutive downward trend for the last three days, resulting in a total decline of 2.42% during this period. Additionally, SPARC's performance over various time frames shows significant underperformance, with a year-to-date decline of 29.54% and a one-year return of -35.36%. The company is facing challenges, including a negative book value and weak long-term fundamental strength, as evidenced by a poor annual growth rate in net sales and operating profit over the last five years. Furthermore, the company's ability to service its debt is concerning, highlighted by a negative EBIT to interest ratio.
In the broader market context, SPARC's recent performance contrasts sharply with the benchmark, as it has consistently underperformed against the BSE500 over the last three years. While the benchmark has shown a positive return of 5.15% year-to-date, SPARC's significant decline indicates a lack of investor confidence. Despite a rise in delivery volume, suggesting increased investor participation, the overall sentiment remains negative due to the company's financial struggles and recent poor quarterly results. This combination of factors contributes to the stock's downward trajectory in the current market environment.